Clinical trials
Pseudophakia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 11 |
| Enrolling by invitation | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Berkeley Eye Center | 4 |
| Eye Hospital Pristina Kosovo | 4 |
| Medicontur Medical Engineering Ltd | 4 |
| Brighton and Sussex University Hospitals NHS Trust | 3 |
| Medical University of Vienna | 3 |
| Democritus University of Thrace | 2 |
| Innovative Medical | 2 |
| Toyos Clinic | 2 |
| Vance Thompson Vision | 2 |
| Vienna Hospital Association | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pseudophakia | 54 |
| Cataract | 24 |
| Presbyopia | 9 |
| Myopia | 7 |
| Hyperopia | 6 |
| Refractive Errors | 4 |
| Capsule Opacification | 3 |
| Aphakia | 2 |
| Astigmatism | 2 |
| Inflammation | 2 |
Trials
Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.